Please use this identifier to cite or link to this item: http://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/2186
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaul, A.
dc.contributor.authorKumar, S.
dc.contributor.authorKalita, S.
dc.contributor.authorSarkar, D.
dc.contributor.authorBhunia
dc.contributor.authorBandyopadhyay, A.
dc.contributor.authorMondal, A. C.
dc.contributor.authorMandal, B.
dc.date.accessioned2021-07-23T00:22:38Z
dc.date.available2021-07-23T00:22:38Z
dc.date.issued2021-07-23
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2186
dc.description.abstractSynthetic antibodies hold great promise in combating diseases, diagnosis, and a wide range of biomedical applications. However, designing a therapeutically amenable, synthetic antibody that can arrest the aggregation of amyloid-b (Ab) remains challenging. Here, we report a flexible, hairpin-like synthetic paratope (SP1, 2 kDa), which prevents the aggregation of Ab monomers and reverses the preformed amyloid fibril to a non-toxic species. Structural and biophysical studies further allowed dissecting the mode and affinity of molecular recognition events between SP1 and Ab. Subsequently, SP1 reduces Ab-induced neurotoxicity, neuronal apoptosis, and ROS-mediated oxidative damage in human neuroblastoma cells (SH-SY5Y). The non-toxic nature of SP1 and its ability to ameliorate hippocampal neurodegeneration in a rat model of AD demonstrate its therapeutic potential. This paratope engineering module could readily implement discoveries of cost-effective molecular probes to nurture the basic principles of protein misfolding, thus combating related diseases.en_US
dc.language.isoen_USen_US
dc.titleAn explicitly designed paratope of amyloid-b prevents neuronal apoptosisin vitroand hippocampal damage in rat brainen_US
dc.typeArticleen_US
Appears in Collections:Year-2021

Files in This Item:
File Description SizeFormat 
Full Text.pdf1.9 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.